Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

61.

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.

Nature.
Do R, Stitziel NO, Won HH, Jørgensen AB, Duga S, Angelica Merlini P, Kiezun A, Farrall M, Goel A, Zuk O, Guella I, Asselta R, Lange LA, Peloso GM, Auer PL, Girelli D, Martinelli N, Farlow DN, DePristo MA, Roberts R, Stewart AF, Saleheen D, Danesh J, Epstein SE, Sivapalaratnam S, Hovingh GK, Kastelein JJ, Samani NJ, Schunkert H, Erdmann J, Shah SH, Kraus WE, Davies R, Nikpay M, Johansen CT, Wang J, Hegele RA, Hechter E, Marz W, Kleber ME, Huang J, Johnson AD, Li M, Burke GL, Gross M, Liu Y, Assimes TL, Heiss G, Lange EM, Folsom AR, Taylor HA, Olivieri O, Hamsten A, Clarke R, Reilly DF, Yin W, Rivas MA, Donnelly P, Rossouw JE, Psaty BM, Herrington DM, Wilson JG, Rich SS, Bamshad MJ, Tracy RP, Cupples LA, Rader DJ, Reilly MP, Spertus JA, Cresci S, Hartiala J, Tang WH, Hazen SL, Allayee H, Reiner AP, Carlson CS, Kooperberg C, Jackson RD, Boerwinkle E, Lander ES, Schwartz SM, Siscovick DS, McPherson R, Tybjaerg-Hansen A, Abecasis GR, Watkins H, Nickerson DA, Ardissino D, Sunyaev SR, O'Donnell CJ, Altshuler D, Gabriel S, Kathiresan S.
| Feb 5, 2015
62.

The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.

Nat. Med.
Grozovsky R, Begonja AJ, Liu K, Visner G, Hartwig JH, Falet H, Hoffmeister KM.
| 12 08, 2014
63.

Mutations in G protein β subunits promote transformation and kinase inhibitor resistance.

Nat. Med.
Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, Gritsman K, Gotlib J, Deininger MW, Makishima H, Turley SJ, Javidi-Sharifi N, Maciejewski JP, Jaiswal S, Ebert BL, Rodig SJ, Tyner JW, Marto JA, Weinstock DM, Lane AA.
| 12 08, 2014
64.

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.

N. Engl. J. Med.
Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M, Schuster SJ, Millenson MM, Cattry D, Freeman GJ, Rodig SJ, Chapuy B, Ligon AH, Zhu L, Grosso JF, Kim SY, Timmerman JM, Shipp MA, Armand P.
| Jan 22, 2015
65.

Clinic-community linkages for high-value care.

N. Engl. J. Med.
Sequist TD, Taveras EM.
| Dec 4, 2014
66.

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.

Lancet.
Elmariah S, Mauri L, Doros G, Galper BZ, O'Neill KE, Steg PG, Kereiakes DJ, Yeh RW.
| Feb 28, 2015
67.

The war against heart failure: the Lancet lecture.

Lancet.
Braunwald E.
| Feb 28, 2015
68.

p53 prevents neurodegeneration by regulating synaptic genes.

Proc. Natl. Acad. Sci. U.S.A.
Merlo P, Frost B, Peng S, Yang YJ, Park PJ, Feany M.
| Dec 16, 2014
69.

Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue.

Nat. Immunol.
Lynch L, Michelet X, Zhang S, Brennan PJ, Moseman A, Lester C, Besra G, Vomhof-Dekrey EE, Tighe M, Koay HF, Godfrey DI, Leadbetter EA, Sant'Angelo DB, von Andrian U, Brenner MB.
| 12 01, 2014
70.

DNA repair. Mechanism of DNA interstrand cross-link processing by repair nuclease FAN1.

Science.
Wang R, Persky NS, Yoo B, Ouerfelli O, Smogorzewska A, Elledge SJ, Pavletich NP.
| Nov 28, 2014
71.

Monoallelic expression of the human FOXP2 speech gene.

Proc. Natl. Acad. Sci. U.S.A.
Adegbola AA, Cox GF, Bradshaw EM, Hafler DA, Gimelbrant A, Chess A.
| Nov 24, 2014
72.

A proteome-scale map of the human interactome network.

Cell.
Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S, Lemmens I, Fontanillo C, Mosca R, Kamburov A, Ghiassian SD, Yang X, Ghamsari L, Balcha D, Begg BE, Braun P, Brehme M, Broly MP, Carvunis AR, Convery-Zupan D, Corominas R, Coulombe-Huntington J, Dann E, Dreze M, Dricot A, Fan C, Franzosa E, Gebreab F, Gutierrez BJ, Hardy MF, Jin M, Kang S, Kiros R, Lin GN, Luck K, MacWilliams A, Menche J, Murray RR, Palagi A, Poulin MM, Rambout X, Rasla J, Reichert P, Romero V, Ruyssinck E, Sahalie JM, Scholz A, Shah AA, Sharma A, Shen Y, Spirohn K, Tam S, Tejeda AO, Trigg SA, Twizere JC, Vega K, Walsh J, Cusick ME, Xia Y, Barabási AL, Iakoucheva LM, Aloy P, De Las Rivas J, Tavernier J, Calderwood MA, Hill DE, Hao T, Roth FP, Vidal M.
| Nov 20, 2014
73.

An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.

Nature.
Banks AS, McAllister FE, Camporez JP, Zushin PJ, Jurczak MJ, Laznik-Bogoslavski D, Shulman GI, Gygi SP, Spiegelman BM.
| Jan 15, 2015
74.

Meal frequency and timing in health and disease.

Proc. Natl. Acad. Sci. U.S.A.
Mattson MP, Allison DB, Fontana L, Harvie M, Longo VD, Malaisse WJ, Mosley M, Notterpek L, Ravussin E, Scheer FA, Seyfried TN, Varady KA, Panda S.
| Nov 25, 2014
75.

G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments.

Proc. Natl. Acad. Sci. U.S.A.
Ivanov P, O'Day E, Emara MM, Wagner G, Lieberman J, Anderson P.
| Dec 23, 2014
76.

When should aspirin be used for prevention of cardiovascular events?

JAMA.
Gaziano JM, Greenland P.
| Dec 17, 2014
77.

Progress against cardiovascular disease: putting the pieces together.

JAMA.
Greenland P, Peterson ED, Gaziano JM.
| Nov 19, 2014
79.

Population and personalized medicine in the modern era.

JAMA.
Mega JL, Sabatine MS, Antman EM.
| Nov 19, 2014
80.

High-cost generic drugs--implications for patients and policymakers.

N. Engl. J. Med.
Alpern JD, Stauffer WM, Kesselheim AS.
| Nov 13, 2014